View Older Stories View More Recent Stories

Mar 30, 2023 05:07PM Form SC 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 30, 2023 05:03PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 29, 2023 05:14PM Form SC 13D/A DICE Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 27, 2023 05:00PM Form SC 13G CureVac N.V. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 20, 2023 04:30PM Form SC 13G Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 16, 2023 08:00AM Jnana Therapeutics to Present Preclinical Data on its PKU Program at the 2023 Society for Inherited Metabolic Disorders Annual Meeting

Mar 15, 2023 09:00AM Adela to present data demonstrating detection of multiple cancer types at the American Association for Cancer Research Annual Meeting 2023

Mar 12, 2023 04:07PM RA Capital Urges Swift Federal Response to SVB Crisis

Mar 7, 2023 08:00AM LENZ Therapeutics Announces $83.5 Million Series B Financing to Advance its Presbyopia Treatments LNZ100 and LNZ101 and Provides Update on Ongoing Phase 3 Studies

Mar 7, 2023 08:00AM MBX Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Mar 6, 2023 06:30AM Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer

Mar 6, 2023 06:03AM Orchard Therapeutics Plc (ORTX) Enters Up to $188M Strategic Financing

Mar 6, 2023 06:00AM Orchard Therapeutics Announces Strategic Financing Totalling up to $188 Million

Mar 6, 2023 06:00AM Orchard Therapeutics Announces Strategic Financing Totalling up to $188 Million

Mar 2, 2023 09:00AM TeraPore Technologies Raises $10M to Bring Precision Nanofiltration Solutions to New Markets

Mar 1, 2023 08:00AM Jnana Therapeutics to Participate in Upcoming Investor Conferences

Feb 28, 2023 07:00AM Third Annual Science2Startup (S2S)™ Symposium on May 3, 2023 Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors

Feb 27, 2023 04:59PM Form SC 13G/A Enliven Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 24, 2023 04:38PM Form SC 13D Mineralys Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 23, 2023 05:20PM Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million

Feb 21, 2023 12:00AM Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders

Feb 16, 2023 07:00AM Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders

Feb 14, 2023 05:17PM Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 05:15PM Form SC 13G/A IO Biotech, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 05:14PM Form SC 13G/A Inhibrx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 05:13PM Form SC 13G/A EyePoint Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 05:11PM Form SC 13G/A Pyxis Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 05:11PM Form SC 13G/A BELLUS Health Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:52PM Form SC 13G/A Milestone Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:52PM Form SC 13G/A Day One Biopharmaceutica Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:52PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31

Feb 14, 2023 04:51PM Form SC 13G/A Kinnate Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A Entera Bio Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A Cogent Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A IMARA Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:51PM Form SC 13G/A Third Harmonic Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:49PM Form SC 13G/A ImmunoGen, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:49PM Form SC 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:49PM Form SC 13G/A NanoString Technologies Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:49PM Form SC 13G HilleVax, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:49PM Form SC 13G/A Instil Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:49PM Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:48PM Form SC 13G/A SYNLOGIC, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:48PM Form SC 13G/A 5:01 Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2023 04:48PM Form SC 13G/A Vera Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

View More Recent Stories View Older Stories